| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $33.63B | $21.70B | $17.68B |
| YoY Revenue Growth % | +55.0% | +22.7% | — |
| Gross Profit | $10.26B | $8.39B | — |
| Gross Margin % | 30.5% | 38.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.74B | $4.99B | $4.07B |
| Operating Margin % | 17.1% | 23.0% | 23.0% |
| Net Income (GAAP) | $3.39B | $3.04B | $2.66B |
| EBITDA (Normalized) | $8.26B | $6.61B | $4.71B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.60B | $4.89B | $4.42B |
| Capital Expenditures (CapEx) | $3.15B | $2.02B | $795.5M |
| Free Cash Flow (FCF) | $2.45B | $2.87B | $3.63B |
| FCF Margin % | 7.3% | 13.2% | 20.5% |
| Return on Invested Capital (ROIC %) | 8.5% | 8.3% | 16.0% |
| Cash & Short-Term Equivalents | $78.0M | $733.0M | — |
| Total Debt (Short + Long Term) | $30.75B | $31.02B | $7.77B |
| Total Stockholders' Equity | $22.48B | $17.04B | $15.95B |